Salivary Acetylcholinesterase Activity Is Increased in Parkinson’s Disease: A Potential Marker of Parasympathetic Dysfunction
Introduction. Decreased salivary flow and xerostomia are frequent findings in Parkinson’s disease (PD), possibly caused by alterations in the parasympathetic tonus. Here we explore salivary acetylcholinesterase (AChE) activity as a potential biomarker in PD. Methods. We measured salivary flow, AChE...
Main Authors: | Tatyana Fedorova, Cindy Soendersoe Knudsen, Kim Mouridsen, Ebba Nexo, Per Borghammer |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2015/156479 |
Similar Items
-
Gastrointestinal Dysfunction in Parkinson’s Disease
by: Casper Skjærbæk, et al.
Published: (2021-01-01) -
Imaging Parkinson’s disease below the neck
by: Per Borghammer, et al.
Published: (2017-04-01) -
Beneficial Effects of Yoga Stretching on Salivary Stress Hormones and Parasympathetic Nerve Activity
by: Nobuhiko Eda, Hironaga Ito, Takao Akama
Published: (2020-12-01) -
Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease
by: Yanmei Chen, et al.
Published: (2020-07-01) -
Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer?
by: Sedigheh Bakhtiari, et al.
Published: (2017-01-01)